Physician

Jacqueline A Mullvain, MD

According to 2025 Medicare claims, Jacqueline Mullvain, MD (NPI: 1528387131) practices hematology/oncology in the Madison, WI market, with the plurality of this provider's patient population coming from Dane, WI. This provider's primary affiliated billing organization is DEAN HEALTH SYSTEMS, INC (NPI: 1053358846; TIN: 391128616) and primary practice location at 53715-1909. Mullvain is affiliated with the SSM WI ACO LLC (ACO ID: A5124), participating under the MSSP model.

Mullvain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 228 traditional Medicare patients, billed 30,882 HCPCS/CPT codes, and received $859,133 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 723 prescription claims across 140 beneficiaries totaling $1,065,434 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 36 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $34,526 to $1,065,434. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	67	5,027	$71,993
2017	198	27,282	$517,965
2018	267	48,766	$867,815
2019	263	80,048	$1,671,790
2020	262	74,989	$1,857,437
2021	296	78,127	$1,890,289
2022	350	68,762	$1,589,252
2023	275	41,014	$892,541
2024	228	30,882	$859,133

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	12	27	$34,526
2016	29	67	$39,868
2017	70	375	$38,059
2018	112	793	$393,865
2019	140	1,120	$730,941
2020	144	1,230	$945,300
2021	148	1,201	$823,528
2022	168	1,055	$1,442,791
2023	137	814	$1,362,746
2024	140	723	$1,065,434

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$940
2019	N/R	16	$422
2020	N/R	12	$1,025
2021	N/R	41	$1,874
2022	N/R	N/R	N/R
2023	N/R	32	$2,201
2024	N/R	36	$1,521

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	77	229	$127
96413	Administration of chemotherapy into vein, 1 hour or less	42	114	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	93	147	$80
36415	Insertion of needle into vein for collection of blood sample	48	154	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	35	176	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	30	900	$481,223
Imbruvica	Ibrutinib	12	336	$210,720
Eliquis	Apixaban	14	420	$7,997
Dexamethasone	Dexamethasone	64	1,333	$807
Anastrozole	Anastrozole	22	1,980	$467

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$883
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$412
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Jacqueline A. Mullvain, MD?

Tedicare shows public-source Medicare data for Jacqueline A. Mullvain, MD (NPI 1528387131), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jacqueline A. Mullvain, MD have ACO affiliation data?

Jacqueline A. Mullvain, MD is shown with ACO affiliation data for SSM WI ACO LLC (MSSP, ACO ID A5124).

What billing organization is linked to Jacqueline A. Mullvain, MD?

Jacqueline A. Mullvain, MD is linked to DEAN HEALTH SYSTEMS, INC (billing NPI 1053358846) in the available physician profile data.

Does Jacqueline A. Mullvain, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.